| Synonyms: | |
| Status: | Phase 1 |
| Entry Type: | Antibody |
| Molecule Category: | UNKNOWN |
| UNII: | Y4U029R8MS |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | Interleukin 17A inhibitor |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Psoriasis | 3 | D011565 | ClinicalTrials |
| Spondylitis, Ankylosing | 2 | D013167 | ClinicalTrials |
| Lupus Nephritis | 2 | D008181 | ClinicalTrials |
| Arthritis, Psoriatic | 2 | D015535 | ClinicalTrials |
| Graves Ophthalmopathy | 2 | D049970 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL4298102 |
| FDA SRS | Y4U029R8MS |
CONTENTS